Cargando…
LncRNA NORAD as a Novel Predictor of Lymph Node Metastasis and Prognosis in Solid Tumors: A Systematic Review and Meta-Analysis
BACKGROUND: Non-coding RNA-activated by DNA damage (NORAD), a novel identified lncRNA, was found to be aberrantly expressed in various types of cancer. This meta-analysis was performed to evaluate the value of lncRNA NORAD as a prognostic biomarker in human cancers. METHODS: We searched PubMed, Web...
Autores principales: | Ye, Tao, Ye, Zhangqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543145/ https://www.ncbi.nlm.nih.gov/pubmed/33016254 http://dx.doi.org/10.1177/1533033820963586 |
Ejemplares similares
-
Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors
por: Song, Wei, et al.
Publicado: (2017) -
Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis
por: Wang, Han, et al.
Publicado: (2017) -
Predictors of lymph node metastasis and residual tumor in early gastric cancer patients after noncurative endoscopic resection: a systematic review and meta-analysis
por: Jiang, Bolun, et al.
Publicado: (2020) -
Diagnostic value of conventional endoscopic ultrasound for lymph node metastasis in upper gastrointestinal neoplasia: A meta-analysis
por: Chen, Cong, et al.
Publicado: (2023) -
Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis
por: Jiang, Kai-Yuan, et al.
Publicado: (2021)